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Abstract
Background: Several chronic inflammatory diseases are characterized by inappropriate CD4+ T cell response. In the
present study, we assessed the ability of Capparis spinosa L. (CS) preparation to orientate, in vivo, the immune response
mediated by CD4+ T cells towards an anti-inflammatory response.
Methods: The in vivo study was carried out by using the contact hypersensitivity (CHS) model in Swiss mice. Then we
performed a histological analysis followed by molecular study by using real time RT-PCR. We also realized a phytochemical
screening and a liquid-liquid separation of CS preparation.
Results: Our study allowed us to detect a significantly reduced edema in mice treated with CS preparations relative to
control. CS effect was dose dependent, statistically similar to that observed with indomethacin, independent of the plant
genotype and of the period of treatment. Furthermore, our histology studies revealed that CS induced a significant
decrease in immune cell infiltration, in vasodilatation and in dermis thickness in the inflammatory site. Interestingly, we
showed that CS operated by inhibiting cytokine gene expression including IFNγ, IL-17 and IL-4. Besides, phytochemical
screening of CS extract showed the presence of several chemical families such as saponins, flavonoids and alkaloids.
One (hexane fraction) out of the three distinct prepared fractions, exhibited an anti-inflammatory effect similar to that
of the raw preparation, and would likely contain the bioactive(s) molecule(s).
Conclusions: Altogether, our data indicate that CS regulates inflammation induced in vivo in mice and thus could be a
source of anti-inflammatory molecules, which could be used in some T lymphocyte-dependent inflammatory diseases.
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Background
Many chronic inflammatory diseases are characterized
by inappropriate or dysregulated CD4+ T cell response
[1]. CD4+ T cells play a major role in the induction and
regulation of immune responses, mainly by secreting cy-
tokines. Given their central role in regulating innate and
adaptive immunity, CD4+ T cells represent a key for
both immune protection and immune pathology [1].
The discovery of a new CD4+ T cell subset, Th17, has
transformed our understanding of the development of
an increasing number of chronic immune-mediated dis-
eases. Contact hypersensitivity (CHS) can be induced in
animals; on which could be used as a model in which
several basic immunological mechanisms can be studied
[2]. Traditionally, CHS represents the prototype of
delayed-type hypersensitivity, which is mediated by T
cells [3–5]. In mice, CHS has been studied using haptens
such as dinitrofluorobenzene (DNFB), FITC, and oxazo-
lone [2, 6]. The CHS reaction consists of two distinct
phases, the afferent phase and the efferent phase [5–7].
During the afferent or the sensitization phase, animals
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are epicutaneously exposed to haptens, the first contact
of a hapten with skin leads to its binding to an endogen-
ous protein in the skin where they form immunogenic
hapten-carrier complexes [2]. The haptens induce local
inflammation by acting on keratinocytes and innate im-
munity receptors. Activation of the skin innate immunity
including keratinocytes induces the production of medi-
ators (IL-18, IL-1β, TNF-γ, ATP, PGE2, LTB4, ROS, his-
tamine, CCL20) by resident skin cells. These mediators
are able to induce the recruitment, migration and
activation of cutaneous antigen presenting cells (APC)
[2, 6, 8]. The hapten-carrier complex is taken up by
Langerhans cells (LCs) and dermal dendritic cells
(dDCs) which migrate from the epidermis to the drain-
ing lymph node (in a CCR7-CCL19/CCL21-dependent
manner), where they present the haptenated peptides to
naive T cells which are subsequently activated [9, 10].
The newly activated T cells proliferate, resulting in the
generation of effector/memory T cells and migrate out
of the lymph node into circulation. During the efferent
or the elicitation phase, animals are reexposed to the
same hapten at a remote skin site. Once more, hapte-
nated peptides are uptaken by skin APC, which present
to hapten specific primed T cells patrolling in the skin.
This results in the recruitment of antigen-specific T cells
to the site of challenge and leads to T cell-mediated tis-
sue damage [2, 6, 8]. This reaction involves both Th1
cells, which release pro-inflammatory cytokines, such as
IFN-γ [3] and Th17 cells, which release IL-17 family cy-
tokines [11, 12]. However, studies have revealed that the
Th2 cells are necessary during the elicitation phase of
the CHS reaction [5]. Therefore, many research efforts
are focusing on the identification of anti-inflammatory
agents able to effectively reduce the inflammatory medi-
ators produced by CD4+ T cells.
The medicinal plants represent a rich source of biologic-
ally active compounds with potential therapeutic applica-
tions [13]. Capparis spinosa L. (CS) is a small shrub
belonging to the family of the Capparidaceae, and the
genus Capparis. It is grown in the Mediterranean region
and also in the dry regions in West and central Asia [14].
In Morocco, CS is found abundantly in different regions es-
pecially in the regions of Fez, Taounate, Meknes, Marra-
kech and Safi [15, 16]. It has been suggested that CS would
be a good candidate for new drug discovery [17]. Biological
studies of various parts of this plant have revealed diverse
bioactivities, including antihepatotoxic [18], anti-allergic
and anti-histaminic [19], anti-oxidative [20, 21], anti-
arthritic [22], hypolipidemic [23], and chondroprotective ef-
fects [24]. However, the immunomodulatory effect of CS is
still not entirely established. Recently, we have shown that.
non toxic doses of CS preparation induce an overall anti-
inflammatory response in vitro in human PBMCs from
healthy donors through significant inhibition of the
proinflammatory cytokine IL-17 and induction of IL-4 gene
expression [25]. In this study, we have used CS preparations
to check whether they contain natural substances able to
orient the immune response mediated by CD4+ T cells in
vivo and thus generating an anti-inflammatory state. We
found that CS inhibited the DNFB-mediated CHS reaction
in mice. The anti-inflammatory effect observed with CS
was independent of the plant genotype and of the period of
treatment. Furthermore, the treatment with CS 24 h after
the initiation of the disease also significantly suppressed the
inflammation. It is noteworthy that CS anti-inflammatory
effect was similar to that observed with the well-established
anti-inflammatory compound, indomethacin. Histological
studies showed an inhibition of cell infiltration to the in-
flammation site following treatment with CS. Interestingly,
Real time PCR analysis revealed a suppression of cytokine
gene expression, including the pro-inflammatory cytokine
IL-17, in the draining lymph nodes of CS-treated mice. Fi-
nally, phytochemical analysis of CS preparation showed the
presence of five chemical compounds; and it is suggested




2,4-dinitro-1-fluorobenzene (DNFB), acetone, potassium
phosphate dibasic puriss (K2HPO4), potassium phos-
phate monobasic puriss (KH2PO4), dimethyl sulfoxide
(DMSO) and potassium chlorid (Kcl) were obtained
from SigmaAldrich. TRIzol reagent, SuperScript™ III
Reverse Transcriptase, oligo(dT)12–18, RNaseOUT™
Recombinant RNase Inhibitor and the fluorescent SYBR
Green Supermix from Invitrogen. Methanol, absolute
ethanol, Acetic acid, Hexane and ethylacetate were from
VWR PROLABO chemicals (BDH). Hematoxylin from
Solvachim, Eosin gelblich from MERCK. Indomethacin
was obtained from PHARMA 5. Digital caliper (Nobel),
digital biological microscope (Motic), NanoVueTM Plus
Spectrophotometer (GE Healthcare, UK) and Real-Time
PCR system (Applied Biosystem FAST 7500) were used.
Animals
Swiss albino mice (25-27 g) were used. They were
obtained from the institute Pasteur of Casablanca-
Morocco. Before initiation of experiments, the mice
were acclimatized for a period of 7 days under standard
environmental conditions. They have had free access to
food and water and were kept in a room with 12 h day/
night cycle. All efforts were made to minimize animals
suffering and to reduce the number of animals used in
the study. The project was approved by the Ethic com-
mittee for biomedical research of the Faculty of Medi-
cine and Pharmacy of Casablanca, Hassan II University,
Casablanca, Morocco. Under reference number, 07/16
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Contact hypersensitivity model
Unanesthetized Swiss mice were sensitized on Days 0
and 1 by applying 50 μl of 0.5% 2.4-dinitro-1-fluoroben-
zene (DNFB) dissolved in acetone/olive oil (4:1, v/v) on
the shaved abdominal skin (positive control), negative
control mice were shaved and painted with the acetone-
olive oil mixture alone. Six days later, the baseline right
ear thickness was measured with a digital caliper then
the interior and external surfaces of right ears were chal-
lenged with 20 μl of 0.2% DNFB. Ear swelling was calcu-
lated as ear thickness 24 h after challenge (then every
other 24 h as shown in the corresponding figures).
Baseline ear thickness was subtracted from the obtained
value. Ear thickness was measured in a blinded manner;
all groups comprised five or seven animals.
Plant material
The leaves of three specimen of Capparis spinosa L.
were collected in August, from three stations in the sur-
roundings of Safi region (in Morocco). The plant mater-
ial was identified and a voucher specimen has been
deposited under number 93664, in the Herbarium
Chérifien Scientific Institute of Rabat, Morocco. The
plant material was dried at room temperature.
Extraction
The leaves were washed and dried under shade and
manually crushed into powder. The powder was ex-
tracted by cold maceration method at room temperature
using methanol or ethanol for 48 h to obtain the metha-
nol or ethanol extract. The solvent extract was filtered
using a millipore filter to remove particulate matter. The
filtrate obtained was concentrated in rotary evaporator
at 37 °C. This resulting preparation was used for the
anti-inflammatory and phytochemical studies. The ex-
tract was conserved at 4 °C in the dark.
Capparis spinosa L phenotyping
Morphological analysis was performed on the aerial
parts of the sampled caper. Quantitative and qualitative
traits were measured in leaves, flower buds and mature
flowers, thorns and twigs stipular. For each sample, five
replicates were measured and recorded, and the average
was used in the subsequent analysis.
Capparis spinosa L genotyping
Total DNA was extracted from the leaves of fresh and
dried caper sampled in the three aforementioned sta-
tions according to the non-commercial basic protocol
described by Doyle based on cationic detergent CTAB
(Hexadecyltrimethyl ammonium bromide) modified [26,





Amplification reactions were performed in a thermal
cycler TC-3000. The amplification conditions were as
follows: initial denaturation step of 5 min (94 °C), 35 cy-
cles of 30 s at 94 °C, 1 min at 52 to 66 °C (depending on
the primer pair used), 1 min at 72 °C. The reaction was
completed by a final elongation step of 7 min at 72 °C.
Phytochemical analysis
The methanol extract was subjected to phytochemical
analysis for constituent identification using the phyto-
chemical methods, which were previously described [28].
In general, tests for the presence or absence of phyto-
chemical compounds involved the addition of an appro-
priate chemical agent to the preparation in a test tube.
The mixture is then vortexed. The presence or absence
of saponins, flavonoids, tannins, alkaloids is subse-
quently detected.
Fractionation
The methanol extract was subjected to fractionation
with hexane and ethyl acetate. 7 g of the methanol ex-
tract was suspended in 20 ml distilled water at 35 °C
and successively extracted with 40 ml of hexane for
10 min (×5) and 40 ml of ethyl acetate for 10 min (×4)
by liquid-liquid extraction. At the end of the extraction,
the three fractions, hexane (F1), ethyl acetate (F2) and
aqueous fraction (F3) have been concentrated in a rotary
evaporator respectively at temperatures of 35 °C, 35 °C
and 40 °C. All the fractions (except F2, were solubilized
with 5% DMSO) were solubilized with Phosphate-Buffered
Saline (PBS) and tested for anti-inflammatory activity.
Treatment protocol
The plant extract and fractions were solubilized in PBS
and administered by intraperitoneal injection (i.p.) for 7,
4, 3 or 2 days at doses of 1.07 g/Kg and 0.428 g/Kg body
weight for methanol extract; 1.07 g/Kg for ethyl acetate
fraction and ethanol extract; 0.30 g/Kg for hexane frac-
tion and 0.38 g/Kg for aqueous fraction. Another group
received i.p. injections of indomethacin at a dose of
2 mg/kg for three consecutive days after challenge.
Though indomethacin is sparingly soluble in PBS, a
homogenous solution was achieved by constant agitation
stirring. The volume used was of 100 μl. The control ani-
mal group received the same volume of PBS. Mice were
randomly divided into eight groups (n = 5) as follows:
Group I: negative control (control -), mice were sensi-
tized by mixture vehicle alone, challenged with DNFB
and received i.p. injections of normal saline; Group II:
positive control (control +), mice were sensitized and
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challenged with DNFB and received i.p. injections of
normal saline; Group III: indomethacin (INDO), mice
were sensitized and challenged with DNFB and received
i.p. injections of indomethacin 24, 48 and 72 h after
challenge; Group IV: methanol extract (CS Met or CS),
mice were sensitized and challenged with DNFB and
received i.p. injections of methanol extract on days -1, 0,
1, 2, 5, 6 and 7, surrounding sensitization and challenge;
Group V: ethanol extract (CS Eth), mice were sensitized
and challenged with DNFB and received i.p. injections of
methanol extract on days -1, 0, 1, 2, 5, 6 and 7, surround-
ing sensitization and challenge; Group VI: methanol ex-
tract (CS.S), mice were sensitized and challenged with
DNFB and received i.p. injections of methanol extract on
days -1, 0, 1 and 2, surrounding sensitization; Group VII:
methanol extract (CS.C), mice were sensitized and chal-
lenged with DNFB and received i.p. injections of methanol
extract on days 5, 6 and 7, surrounding challenge; Group
VIII: methanol extract (CS.T) or fractions, mice were sen-
sitized and challenged with DNFB and received i.p. injec-
tions of extract 2 or 3 days after challenge on days 7, 8
and 9. Ear swelling was calculated as ear thickness after
challenge minus ear thickness before challenge.
Histology
48 h after challenge, immediately after sacrifice by cer-
vical dislocation, the individual ears were collected by
dissection and fixed in 10% phosphate buffered formalin
for 48 h. The ears were thereafter dehydrated in graded
concentrations of alcohol (70%, 80%, 90% and 100% x 2),
cleared in toluene and embedded in paraffin at 60 °C.
The paraffin-embedded tissue sections were cut on a
microtome at 3 μm through the midsagittal plane,
mounted on clean glass slides and dried for 30 min at
60 °C. The sections were stained with haematoxylin and
eosin (H&E), and examined by Motic digital microscope.
A certified pathologist analyzed the samples in a blinded
manner. A minimum of three sections per animal
experimentation was examined for the presence and degree
of thickenes and inflammation of the epidermis and dermis.
Digital photographs were taken at different magnification.
Quantitative real time PCR
Total RNA was extracted using TRIzol reagent (Invitrogen).
Twenty for hours after challenge, immediately after sacri-
fice, individual lymph nodes draining the inflammatory site
were collected, frozen in the presence of Trizol at
−80 °C, untiluse. Total RNA was extracted from the
frozen tissue samples as described by the manufac-
turer. RNA concentration and quality were measured
using the NanoVueTM Plus Spectrophotometer (GE
Healthcare, UK). Then, total RNA was transformed to
first strand complementary DNA (cDNA) by incubat-
ing with SuperScript™ III Reverse Transcriptase using















β-actin was used as an internal standard to evaluate
relative expression of INFγ, IL-4 and IL-17. Expres-
sion level of each gene was measured in duplicate, in
the presence of the fluorescent dye (iQ SYBR Green
Supermix) using a Real-Time PCR system (Applied
Biosystem FAST 7500). Experiments were performed
in a 20 μL reaction volume with specific primer pairs,
and the conditions of real-time quantitative PCR were
as follows: denaturation at 95 °C for 15 s and amplifi-
cation by cycling 40 times at 95 °C for 15 s, 60 °C
for 30 s and 72 °C for 30 s. The values were repre-
sented as normalized expression: 2−ΔCt (ΔCt = Ct tar-
get RNA – Ct β-actin).
Statistical analysis
All the in vivo experiments consisted of five or seven
mice, and all the other determinations were conducted
in duplicate. The statistical significance between mean
values was determined by using student’s t-test. One-
way analysis of variance was used to test the difference
between groups using SPSS software version 15.0.1
(Chicago, IL). P value 0.05 was considered to be sig-
nificant [* p < 0.05; ** p < 0.01; *** p < 0.001]. Data were
expressed as a mean ± SD. Analysis of the identity be-
tween the three samples of caper was performed using
similarity coefficients and dendrograms via PAST soft-
ware version 1.74 (http://folk.uio.no/ohammer/past/).
Results
CS inhibited the DNFB-mediated CHS reaction
To evaluate the anti-inflammatory effect of CS extract in
vivo, female «Swiss» mice were used. Mice were sensi-
tized and challenged with DNFB and received i.p.
injections of either Phosphate-Buffered Saline (PBS)
(positive control) or of CS extract dissolved in PBS at a
predetermined optimal dose of 1,07 g/Kg on days -1, 0,
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1, 2, 5, 6 and 7, encompassing both sensitization and
challenge steps as depicted in (Fig. 1a). Negative control
mice received i.p. injections of PBS or were left un-
treated. The effect of CS extract on CHS progression
was compared with the positive control group. After
challenge, ear thickness was measured as a marker for
clinical manifestation of CHS severity. Treatment with
CS was able to regulate the CHS response in mice
significantly (P < 0.001) at the level of ear in comparison
with control, with an inhibition percentage of approxi-
mately 73.44% (Fig. 1b, c). To check if the protective ef-
fect of CS was influenced by the extraction solvent, or
by the doses of the used extract, mice were sensitized
and challenged with DNFB and received i.p. injections of
methanol extract at doses of 1.07 g/Kg and 0.428 g/Kg
body weight, or ethanol extract at doses of 1.07 g/Kg.
Anti-inflammatory effect of ethanol CS extract has been
observed with differences, which were statistically sig-
nificant, compared with the positive control group.
Swelling of the right ear in the positive control group
persisted 10 days after the challenge, while the swelling
was resolved after 4 days of the challenge for CS-treated
groups. However, the difference observed between
groups treated with the methanol and ethanol CS
extracts was not statistically significant (Fig. 1d). How-
ever, the difference observed between the group treated
with the methanol extract at doses of 1.07 g/Kg and at
doses 0.428 g/Kg was statistically significant (Fig. 1e).
The peak of swelling of the right ear (challenged) was
83 μm in the positive control group, while those in
the groups treated with methanol extracts, at doses of
0.428 g/Kg and 1.07 g/Kg body weight, did not ex-
ceed 41 and 16 μm respectively. The results suggest
that CS significantly inhibited edema in mice and ex-
hibits anti-inflammatory activities in a dose-dependent
manner. Then we wondered whether the observed
anti-inflammatory effect of CS depends on the plant
variety.
Fig. 1 CS methanol extract decreased the CHS reaction. Mice were sensitized on the shaved ventral abdomen on days 0 and 1 by applying 50 μl
of 0.5% DNFB (positive control ■), or were treated with the vehicle alone (negative control●); all groups of mice were challenged with 20 μl of 0.2% DNFB
on the right ears on day 6. a Scheme for the experimental protocol. b Another group of mice was sensitized and challenged with DNFB and received i.p.
injections of CS extract (▲) at a dose of 1.07 g/Kg. c Histograms representing ear swelling 48 h after challenge. d Mice received i.p. injections of either
methanol (▲) or ethanol (▼) CS extracts at a dose of 1.07 g/Kg. e Mice received i.p. injections of CS methanol extract at doses of either of 1.07 g/Kg(▲)
or 0.428 g/Kg body weight (▼) on days -1, 0, 1, 2, 5, 6 and 7. Data were expressed as averages of the values of ear swelling after the challenge. P value
<0.05 was considered to be significant [* p< 0.05; ** p< 0.01; *** p< 0.001]. Data are representative of 3 or 2 number of experiments with n= 5 of mice
per group (Except the negative control) (Additional file 1)
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The anti-inflammatory effect of CS was independent of
the plant genotype and of the period of treatment
Based on Morphological and molecular characterization
we showed that the three specimens of caper studied
correspond to three different genotypes (Fig. 2e, f ). In
order to determine whether the anti-inflammatory
effect of CS preparation could be maintained indiffer-
ent plant genotypes, presenting with phenotypic and
genotypic differences (Fig. 2e, f ), we compared the
effect of our primary extract (genotype 1) with two
other genotypes (2 and 3). Groups of mice sensitized
and challenged with DNFB using the previously de-
scribed protocol, were treated with sample 1, sample
2 or sample 3 of methanol extracts on days -1, 0, 1,
2, 5, 6 and 7. Measures of edema, after the challenge,
suggested that the three samples of CS show a pro-
tective effect. The three samples significantly sup-
pressed the CHS response, but with differences not
statistically significant (Fig. 2a, b). This finding sug-
gests that the anti-inflammatory effect of CS extract


























Fig. 2 The anti-inflammatory effect of CS is independent of the plant genotype and of the period of treatment. Different Groups of mice (≈5 mice
per group) were sensitized on the shaved ventral abdomen on days 0 and 1 by applying 50 μl of 0.5% DNFB (positive control ■), or with the vehicle
alone (negative control●) and were all challenged with 20 μl of 0.2% DNFB on the right ears on day 6. Other groups were sensitized and challenged
with DNFB and received i.p. injections of the first (CS. 1), second (CS.2) or third (CS.3) CS genotypes (a and b). In another series of experiments (c and
d), mice received i.p. injections of CS extract on days -1, 0, 1 and 2 during the period of sensitization (s) or on days 5, 6 and 7, during the period of the
challenge (c) at a dose of 1.07 g/Kg body weight or during the periods of sensitization and challenge (s + c). Data were represented as averages of ear
swelling values after the challenge. P value <0.05 was considered to be significant [* p < 0.05; ** p < 0.01; *** p < 0.001]. e Genetic comparison of the
three varieties of CS presenting with morphological differences. (a): quantitative descriptors, (b): qualitative descriptors and c: Qualitative versus quantitative
descriptors and Photographs of leaves and flowers of these plant varieties. f Molecular profil of samples based on 4 distinct ISSR primers (Additional file 2)
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is not influenced by the phenotypic and genotypic dif-
ferences of the plant.
We have previously shown that treatment with CS
extract, encompassing sensitization and challenge;
inhibited DNFB-mediated CHS reaction. The patho-
physiology of classical CHS is well-known and re-
quires two temporally dissociated steps: the afferent
phase (sensitization) and the efferent phase (challenge
or elicitation). In order to get insight into the mech-
anism of anti-inflammatory effect observed of CS ex-
tract, we analyzed the anti-inflammatory effect of CS
extract in each phase. Experiments were carried out
according to the protocol described in materials and
methods. The results suggest that the inhibition ob-
served with treatments at the level of the two phases
of the induction of the disease (73.57%) is similar to
that observed after treatment during the sensitization
phase only (69,63%) (Fig. 2c). The inhibition observed
with the treatment at the time of the challenge only,
is less important (60.15%), but also not statistically
significant (Fig. 2d). In conclusion, CS preparation
presents similar inhibition of the CHS reaction in the
three distinct situations (administration of the extract
at the time of the sensitization only or at the time of
the challenge only or at the level of the two phases).
The question arose whether CS would also be effect-
ive in inhibiting an already induced CHS response.
Treatment with CS 24 h after the initiation of CHS reaction
also significantly suppressed the inflammation
Mice were sensitized with DNFB on the abdomen in the
absence of CS and were ear challenged 6 days later,
resulting in an efficient ear swelling response. On days 7,
8 and 9, third of mice received i.p. injection of CS,
another third received i.p. injection of the anti-
inflammatory drug Indomethacin and another third re-
ceived i.p. injection of PBS for positive control. Another
group of mice received i.p. injection of CS during both
sensitization and challenge phases (Fig. 3). The treat-
ment with the anti-inflammatory drug Indomethacin
and CS, reduced significantly the ear swelling in com-
parison with the vehicle-treated positive control group
(P < 0.001). However, the difference observed between
the group treated with CS (24 h after disease induction)
and the group treated with CS during sensitization and
challenge and the group treated with Indomethacin is
not statistically significant (Fig. 3a, b). In conclusion, it is
suggested that CS effect is similar to that of a well-
established anti-inflammatory, Indomethacin. On the
other hand, the anti-inflammatory effect of CS persists
even when applied after disease induction.
CS regulated inflammation induced in vivo in mice through
inhibition of cell infiltration and cytokine gene expression
In order to better understand the mechanisms under-
lying the anti-inflammatory effects observed, we assessed
the effect of CS extract on the infiltration of immune
cells in the inflammation site, 48 h after the challenge.
Histopathological analysis of the positive control group
showed anintensified inflammation manifested by in-
crease of ear thickness (edema), excessive inflammatory
cell infiltration, swelling of fibroblasts, dilatation of pap-
illary vessels (vasodilatation), with perivascular lympho-
histiocytic infiltrate, thickening of the dermis and
epidermal hypertrophy (Fig. 4c, d, e). These features are
recognized as the microscopic hallmark of contact
dermatitis [28]. Interestingly, our study demonstrated
that this DNFB-induced features of inflammation were
also suppressed upon CS treatment, as shown in Fig. 4f, g.
CS induced a significant decrease in immune cell in-
filtration, epidermal hypertrophy, dermis thickness,
swelling of fibroblasts and vasodilatation. Indeed, the
anti-inflammatory effect of CS on CHS response was
further corroborated by histological examination of
Fig. 3 Treatment with CS extract following the induction of CHS reaction also significantly inhibited the inflammation. Different Groups of mice
(≈5 mice per group) were sensitized on the shaved ventral abdomen on days 0 and 1 by applying 50 μl of 0.5% DNFB (positive control ■), or with the
vehicule alone (negative control ●) and were all challenged with 20 μl of 0.2% DNFB on the right ears on day 6. Other groups were sensitized and
challenged with DNFB and received i.p. injections of CS extract on days -1, 0, 1, 2, 5, 6 and 7(panel a, CS); or on days 7, 8 and 9, following the induction of
CHS reaction (panel A, CS.T) (▼). In other experiments (panel b), mice received i.p. injections of CS extract (▲) or Indomethacin (▼) at a dose of 1.07 g/Kg
and 2 mg/Kg respectively for three consecutive days following the challenge (24 h, 48 h and 72 h). Data were represented as averages of ear swelling
values after the challenge. P value <0.05 was considered to be significant [* p< 0.05; ** p< 0.01; *** p< 0.001] (Additional file 3)
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the inflamed ear tissue. As T cells are known to be
the critical cell type mediating the CHS response, we
then investigated whether T cell function was affected.
In order to assess the immuno-modulatory efficacy of
CS extract used in this study, the relative expression
of the three key cytokines IFNγ (for Th1 cells), IL-4
(for Th2 cells) and IL-17 (for Th17 cells) in CHS re-
action induced by DNFB, was investigated by RT-
qPCR. CHS and expression of IFNγ, IL-17 and IL-4
mRNA was markedly and significantly suppressed in
mice treated with CS relative to the control (Fig. 5).





Fig. 4 Histological analysis of the skin from the inflammatory site. Paraffin-embedded sections of inflamed skin from negative control (a and b),
positive control (c, d and e) and CS-treated (f and g) mice at 100× and 400×. Mice were sacrificed 48 h after the challenge, and stained with H&E
after formalin fixation and paraffin inclusion (Additional file 4)
Fig. 5 CS inhibited cytokine gene expression in the lymph nodes draining the inflammatory site. Expression of mRNA was investigated by real-
time PCR in positive control mice (sensitized and challenged with DNFB “0.5 and 0.2%”, n = 7), in negative control mice (only challenged by 0.2%
of DNFB, n = 4), and in mice sensitized and challenged with DNFB “0.5 and 0.2%” and treated with CS at this two phases (Cap, n = 6). The analysis
of IFNγ (a), IL-17 (b) and IL-4 (c) mRNA expression is shown. Results are represented as normalized expression: 2 − ΔCt (ΔCt = Ct RNA target – Ct
β-actin). P value <0.05 was considered to be significant [* p < 0.05; ** p < 0.01; *** p < 0.001] (Additional file 5)
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inhibiting cytokine gene expression. A chemical ana-
lysis was subsequently performed in order to identify
the fraction of the extract, which contains the bio-
active compound(s).
Phytochemical screening and identification of the potential
anti-inflammatory fraction of the CS extract
The preliminary extraction of CS leaves with aqueous
methanol extract, which on phytochemical analysis,
showed the presence of five known compounds were
identified as: alkaloids, flavonoids, phenolic compound,
saponins and antraquinones; as shown in Table 1. The
crude extract was subjected to fractionation with hexane
and ethyl acetate, by liquid-liquid extraction. Extraction
of the plant material using different solvents gave three
fractions, hexane fraction (F1), ethyl acetate fraction (F2)
and aqueous fraction (F3). All fractions showed signifi-
cant anti-inflammatory activity, with varying degrees of
anti-inflammatory activities (Fig. 6). Only one fraction
showed very high activity. This hexane fraction (F1) ex-
hibited anti-inflammatory effect similar to that of the
raw extract, with differences not statistically significant
(Fig. 6a). In conclusion, it is suggested that the potential
bioactive molecule of CS extract is probably conserved
in hexane fraction.
Discussion
In the present study, we examined the anti-inflammatory
effect of CS extract in vivo using the animal model of con-
tact hypersensitivity which represents a delayed-type
hypersensitivity reaction, which is mediated by hapten-
specific T cells [29]. Our results showed a significant anti-
inflammatory action of CS. The effect was dose dependent
and was not influenced by the treatment period or by the
genotype of the plant species. This effect was observed
even when treatment was applied after disease induc-
tion and it was similar to that of indomethacin, used
as a positive control. Histology studies also revealed
that CS induced a significant decrease in immune cell
infiltration, in dermis thickness and in vasodilatation.
Using RT-qPCR, we showed that this extract likely
operated by inhibiting cytokine gene expression in-
cluding IL-17, IFNγand IL-4. Chemical analysis
showed the presence of saponins, flavonoids, alka-
loids, phenolics and anthraquinones in the studied ex-
tract. Furthermore, fractionation of the extract
suggested that the potential bioactive(s) molecule(s) is
(are) likely conserved in the hexane fraction.
The in vivo assays allowed us to reveal a significant
anti-inflammatory effect of methanol and ethanol leaf
CS extracts, with an inhibition percentage of approxi-
mately 73.44%. This protection effect was dose
dependent (Fig. 1). The aerial parts and fruit aqueous ex-
tracts of CS, were also found to exhibit significant anti-
inflammatory activities against carrageenan-induced
edema in rats [30, 31]. In other reports, it was also
shown that aerial parts, fruits and flower buds of CS also
exhibit immuno-modulatory properties [30–34]. These
independent studies were using the same species but
carried out in different places and thus probably using
distinct varieties such as those described earlier,
Capparis spinosa L.var. intermis turra and Capparis spi-
nosa L.var. aegyptia [16, 35, 36]. To verify this hypoth-
esis, we compared the effect of three different varieties
of this plant, with phenotypic and genotypic differences;
the initial primary variety (genotype 1) with two other
related varieties (genotypes 2 and 3). Measures of
edema, after the challenge, suggested that the three sam-
ples significantly inhibited the CHS response in mice,
and with differences that are not statistically significant.
This finding suggests that the anti-inflammatory effect
of CS extract is not influenced by the phenotypic and
genotypic variability of this plant (Fig. 2). In order to
better understand the mechanisms underlying CS anti-
inflammatory effect and taking into consideration the
fact that LCs have been considered to be central in the
initiation of CHS reaction in the sensitization phase [9,
37–39], we analyzed the effect of CS in each phase sep-
arately (sensitization and challenge). Our data indicated
that CS exhibits similar degree of inhibition in the two
situations (Fig. 2).
As antigen presentation is required for both
sensitization and elicitation phases of CHS, and in both
cases LC could be involved, we decided to evaluate the
effect of CS later after disease induction. In these condi-
tions, we showed that the anti-inflammatory effect of CS
persisted (Fig. 3). This observation suggests that CS
likely acts independently from LCs. This led us to think
that CS could act on subsequent steps of the induction
of CHS such as T cell activation and/or recruitment into
the inflammatory site.
Upon induction of CHS in mice, the pinna of the ear
is typically utilized to evaluate the inflammatory re-
sponse, which peaks at 24-48 h after challenge, then pro-
gressively decreases through active down-regulating
mechanisms [2, 5, 6]. Therefore, we assessed the effect
of CS 48 h after the induction of CHS reaction.
Table 1 Phytochemical screening of the methanol extract of aerial parts of Capparis spinosa L
Class of compounds Alkaloids Tannins Flavonoids Phenolic compound Coumarins Saponins Anthocyanin Antraquinones
Methanol extract + - + + - + - +
+ : Presence of constituents; – : Absence of constituents
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Histopathological analysis of the skin sections from
positive control mice (treated with DNFB) showed epi-
dermal hypertrophy (thickening of the epidermis), vaso-
dilatation, swelling of fibroblasts and inflammatory cell
infiltrate. These features were not observed in the skin
from negative control mice and were all significantly
decreased in the skin of the group of mice treated with
CS (Fig. 4). A study was undertaken to evaluate the ef-
fect of CS leaves on the testicular tissue and epididymis
in normal and trichloroacetic acid intoxication mice.
This study revealed that leaf powder of CS and honey
attenuated hyperplasia mononuclear cell infiltration
and edema in the epididymis of mice [40]. This obser-
vation is in agreement with the present study and con-
firms that treatment of mice with CS extract suppresses
inflammation, likely by inhibition of immune cell
infiltration.
Since our data suggested that CS likely operated by in-
hibition of immune cell infiltration and not through
LCs, we hypothesized that CS may act in on T cell medi-
ators. Our study revealed that CS induced a significant
decrease in the expression of pro-inflammatory cyto-
kines IFNγ and IL-17 but also of the anti-inflammatory
cytokine IL-4, compared with the positive control group
of mice (mice sensitized and challenged with DNFB)
(Fig. 5). In these experiments, the increased expression
of cytokines detected in negative control groups might
be due to the single treatment with DNFB (challenge) in
this group of mice. This is the first study, at our know-
ledge, showing that CS regulates CHS reaction through
inhibition of immune cell infiltration to the skin and
suppression of cytokine gene expression. This improves
the understanding of CS mechanism of action and pro-
vides new insights into therapeutic strategies for CHS or
any pathology, which is mediated by proinflammatory
cytokinen, IFNγ and IL-17. In agreement with the
present study, we have recently shown that CS signifi-
cantly inhibited the expression of IL-17 in vito in human
PBMCs from healthy donors [25]. However, regulation
of IL-4 by CS showed different results when this was ap-
plied either in vitro in human cells or in vivo in mice.
While, CS showed an increase of IL-4 gene expression
in vitro, it rather revealed a suppression of IL-4 gene ex-
pression in vivo in mice. Several points could account
for this apparent discrepancy, including human versus
mice cells, in vitro versus in vivo analysis. It has been re-
ported, using MTT assay, that protein extracts of the
fruit of CS exhibits a significant immunosuppressive ac-
tivity through the inhibition of proliferation of spleno-
cytes upon stimulation by Con-A [34]. It is likely that
the observed inhibition of CS on cytokine expression is
due to inhibition of proliferation of T cells. It has also
been found that the in vitro exposure of human periph-
eral blood mononuclear cells (PBMCs) to a methanol ex-
tract of CS buds interferes with HSV-2 replication in
PBMCs inhibiting the extracellular virus release by up-
regulating the expression of IL-12, IFN-γ and TNF-α
[32]. These results appear inconsistent with the previ-
ously cited. This could be due to an inter-species differ-
ence; since the former studies were performed in mice
Fig. 6 The hexane fraction of CS reproduced the anti-inflammatory effect. Mice (5 mice per group) were sensitized on the shaved ventral abdomen
on days 0 and 1 by applying 50 μl of 0.5% DNFB (positive control ■), or were treated with the vehicle alone (negative control●); all groups of mice
were challenged with 20 μl of 0.2% DNFB on the right ears on day 6. Other groups of mice were sensitized and challenged with DNFB and received
i.p. injections of crude extract of CS (▲) (panel a, CS), or the hexane fraction of CS (panel a, F1), the ethyl acetate fraction (panel b, F2) or the aqueous
fraction (panel c, F3) (▼). Data were represented as averages of ear swelling values after the challenge. P value <0.05 was considered to be significant
[* p < 0.05; ** p < 0.01; *** p < 0.001] (Additional file 6)
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while the latter in human cells. The apparent discrep-
ancy could also be due to a difference in the bioactive
substances present in CS buds versus CS leaves. On the
other hand, a protein exhibiting an N-terminal amino
acid sequence purified from fresh CS seeds, inhibited
proliferation of hepatoma HepG2 cells, colon cancer
HT29 cells and breast cancer MCF-7 cells with an IC50
of about 1, 40 and 60 mM, respectively [41].
The extraction of CS leaves with methanol showed the
presence of five compounds: alkaloids, flavonoids, phen-
olic compound, saponins and antraquinones. It has in-
deed been reported that biflavonoids from CS fruits
inhibit NF-κB [33], a transcription factor known to play
important roles in various biological processes including
inflammation. NF-κB is also required for activated T cell
survival, proliferation and cytokine gene expression [42].
Inhibition of NF-κB activity prevents GATA-3 expres-
sion and Th2 cytokine production (IL-4, IL-5 and IL-13)
[43]. It also inhibits production of IFNγ by Th1 cells
[42]. Another study supports the importance of NF-κB
activation in Th17 cell differentiation [44]. Therefore,
one possibility could be that CS inhibits cytokine ex-
pression by the inhibition of NF-κB activation. HPLC
analysis performed by our team on CS preparation
revealed the presence of polyphenol compounds in-
cluding catechin, caffeic acid, syringic acid, rutin and
frulinic acid [25].
In our experiments, when the crude extract was sepa-
rated into three fractions, the hexane fraction has
showed anti-inflammatory effect similar to that of raw
extract. Then it is likely that the active molecule is
whithin this fraction. Further experiments are underway
in order to identify and isolate the bioactive molecule
involved.
Conclusion
The current study showed that CS preparation is a po-
tential source of anti-inflammatory agents. CS inhibited
inflammation by down-regulating the expression of pro-
inflammatory cytokines and by inhibiting immune cell
infiltration in the inflammation site. These findings
could be a basis for its potential use in some T cell-
mediated pathologies. Further investigations are, how-
ever, needed in order to identify and characterize the
bioactive compound(s).
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